PCRX Stock Price Chart More Charts

PCRX Price/Volume Stats

Pacira BioSciences, Inc. (PCRX) Company Bio

Pacira Pharmaceuticals develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company was founded in 2006 and is based in Parsippany, New Jersey.

PCRX Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Pacira BioSciences Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Pacira BioSciences Inc ranked in the 80st percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 254.17%. As for the metrics that stood out in our discounted cash flow analysis of Pacira BioSciences Inc, consider:

• The company's compound free cash flow growth rate over the past 4.71 years comes in at 0.81%; that's greater than 89.62% of US stocks we're applying DCF forecasting to.
• Pacira BioSciences Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
• The weighted average cost of capital for the company is 9. This value is greater than 77.91% stocks in the Healthcare sector that generate free cash flow.

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as PCRX, try CCEL, QDEL, AMS, ACHC, and ABC.